# Four-Drug Combination Treatment in Hiv-Infected Subjects Failing Therapy With Antiretroviral Regimens

> **NCT00052117** · PHASE2 · COMPLETED · sponsor: **Pfizer** · enrollment: 300 (—)

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** capravirine
- **DRUG:** Kaletra
- **DRUG:** 2 NRTIs

## Key facts

- **NCT ID:** NCT00052117
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-01
- **Primary completion:** —
- **Final completion:** 2005-05
- **Target enrollment:** 300 (—)
- **Last updated:** 2007-10-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00052117

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00052117, "Four-Drug Combination Treatment in Hiv-Infected Subjects Failing Therapy With Antiretroviral Regimens". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT00052117. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*